amfAR’s newest grant will empower a multi-institutional team of researchers to build the first-ever comprehensive index of HIV reservoir cells and plot a course toward a cure for HIV.
amfAR press release
With an investment of $2 million, amfAR has launched The HIV Immune Atlas Study, a groundbreaking effort aimed at transforming scientific understanding of how the virus disrupts immune function and persists in the body throughout treatment. Despite the efficacy of antiretroviral treatment, a small number of infected cells, known as the HIV reservoir, remain hidden in the body, the primary barrier to a successful HIV cure.
The grant brings together a distinguished team from a global network of renowned research institutions: HIV researchers Nadia Roan, PhD, and Melanie Ott, MD, PhD, of the Gladstone Institutes; Brad Jones, PhD, of Weill Cornell Medicine; and Jeffrey Johnson, PhD, of the Icahn School of Medicine at Mount Sinai, as well as pioneer in biomedical artificial intelligence (AI) and machine learning Fabian Theis, PhD, of Helmholtz Munich.
Read the full press release here.
Source : amfAR
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.